Company Quick10K Filing
Bioethics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2018-03-08 Control, Officers
8-K 2018-02-22 Officers

Bioethics Financials

-

BIOE Metrics, Comps, Filings


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($ Quarter)

Operating, Investing, Financing

Comps ($ TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,294,900,000 1,955,243,000,000 886,324,000,000 2,000,328,000,000 0 -19,719,000,000 98,213,000,000 579,271,900,000
China Crawfish (CACA) 2,499,000 0 0 0 -4,278,000 -4,278,000 -2,501,000
Mirenco (MREO)
Weyland Tech (WEYL) 10,602,385,000 5,279,803,000 29,462,263,000 -957,570,000 -4,242,435,000 -4,098,835,000 -5,302,921,000
Lingo Media (LMDC) 1,302,004,000 743,410,000 0 0 0 0 -1,000
Granite Real Estate (GRP)
Wewin Group (WWIN) 25,735,000 114,327,000 5,000,000 19,659,000 -95,301,000 -95,301,000 -20,011,000
MWF Global (MWF) 125,000 0 -34,156,000 -34,156,000 -569,000
Frontier Digital Media Group (FDMG) 5,245,000 30,791,000 31,784,000 0 -29,127,000 -29,127,000 -3,427,000
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749,000,000 8,029,864,000,000 236,819,000,000 0 0 2,514,000,000 -190,199,002,000
G-Mes Holdings (GMES) 1,262,407,000 812,133,000 651,687,000 608,846,000 66,711,000 140,706,000 -30,825,000
Baynon (BNON) 11,303,000 144,518,000 0 0 -20,995,000 -19,951,000 98,696,000
Immune Therapeutics (IMUN) 0 23,672,000 12,552,994,000 0 33,986,000 -5,080,179,000 -5,078,622,000 -21,398,000
Green Planet Bio Engineering (GPLB) 3,000,960,000 0 271,686,000 0 0 -38,208,000 -38,208,000 3,000,959,000
Blue Sphere (BLSP) 894,407,000 43,956,000,000 86,868,000,000 7,950,000,000 2,700,000,000 -14,453,000,000 -14,295,000,000 8,802,407,000
Therapeutic Solutions (TSOI) 0 367,163,000 1,851,159,000 13,260,000 10,130,000 -1,579,387,000 -1,235,683,000 481,264,000
Stem Holdings (STEMH) 40,803,014,000 5,702,703,000 957,741,000 363,932,000 -8,070,014,000 -7,496,304,000 -5,453,599,000
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27,229,000 16,748,864,000 0 0 -5,795,085,000 -3,051,616,000 893,654,000
Ryanair Holdings (RYAA) 13,250,700,000,000 8,035,800,000,000 0 0 0 0 -34,900,002,000

Balance Sheet ($)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash6,989,0005,807,000010,966,0004,505,0003,595,0005,500,000529,000359,0002,656,0002,546,00058,00011,634,0004,669,00019,00092,879,00024,653,00011,588,00043,030,00069,919,00065,900,00051,684,00040,270,00026,675,0001,724,0001,652,0001,323,000381,00031,698,00064,414,00018,126,000
Accounts Receivable
Inventory
PP&E
Assets6,989,0005,807,000010,966,0004,505,0003,595,0005,500,000529,000359,0003,036,0002,926,000438,00019,134,00010,294,0003,769,00094,754,00074,653,00069,071,00099,881,00071,794,00067,269,00057,482,00043,496,00032,830,0004,807,0002,664,0002,264,0001,250,00032,496,00065,140,00018,781,000
Accounts Payable05,618,000997,00005,366,000423,00003,795,0002,773,0008,439,0001,634,00004,500,00027,252,000
Long-Term Debt
Liabilities53,730,00060,096,00058,405,00077,229,00077,291,00083,692,00089,880,00090,667,00095,672,000106,892,0008,439,0001,809,00025,000,00029,500,00027,550,00051,131,00076,087,000106,312,000178,083,000179,821,000187,331,000188,482,000194,261,000200,744,000189,092,000213,897,000240,901,000253,195,000300,320,000359,139,000330,839,000
Stockholders' Equity-46,741,000-54,289,000-58,405,000-66,263,000-72,786,000-80,097,000-84,380,000-90,138,000-95,313,000-103,856,000-5,513,0001,371,000-5,866,000-19,206,000-23,781,00043,623,000-1,435,000-37,241,000-78,202,000-108,027,000-120,064,000-131,000,000-150,765,000-167,914,000-184,285,000-211,233,000-238,637,000-251,945,000-267,824,000-293,999,000-312,058,000
Income Statement ($)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue000000000000
Cost of Revenue
Gross Profit
R&D
SG&A
Tax00000000000
Net Income-7,548,000-4,116,000-7,858,000-7,311,000-4,282,000-5,758,000-5,175,000-8,543,000-6,657,000995,000-224,386,000-13,340,000-4,575,000-32,596,000-45,057,000-35,807,000-40,961,000-29,825,000-12,035,000-10,938,000-19,765,000-17,149,000-16,371,000-16,948,000-27,404,000-13,308,000-15,879,000-26,175,000-18,059,000
Cash Flow ($)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-1,182,000-6,189,000-8,652,000-910,000-8,095,000-4,971,000-170,000-8,703,000-110,00025,426,000-46,476,000-6,965,000-4,650,000-7,140,000-18,226,000-13,065,000-3,558,000-23,111,000-2,590,000-14,216,000-11,414,000-13,595,000-31,951,000-8,572,000-3,429,000-11,112,000-20,833,000-17,284,000-31,602,000
Cash Investing00000000000-1,429,000
Cash Financing0382,00019,618,000010,000,0000011,000,00014,000,000-24,825,00040,963,00000008,500,0003,100,00010,170,00052,150,00050,000,000-14,686,000